Gibson Christopher, Director of Recursion Pharmaceuticals RXRX, has filed 0 purchases and 115 sales on the open market. Over the past 12 months that comes to a net sale of $3.4M. The latest trade was on 06/05.

GC

GC

Gibson Christopher

Director

Company

Recursion Pharmaceuticals RXRX

First filing

23/01/06

Trades

453 trades

Buys / sales

0 / 115

12-month net buying

−$3.4M

Last trade

06/05

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Recursion PharmaceuticalsRXRX	Open-market sale10b5-1 plan	06/05	06/05	40,000 sh	$3.62	$144,800	−4.3%
Recursion PharmaceuticalsRXRX	Open-market sale10b5-1 plan	05/22	05/27	40,000 sh	$3.08	$123,200	−4.3%
Recursion PharmaceuticalsRXRX	Open-market sale10b5-1 plan	05/07	05/08	40,000 sh	$3.37	$134,800	−4.1%
Recursion PharmaceuticalsRXRX	Open-market sale10b5-1 plan	04/22	04/24	40,000 sh	$3.61	$144,400	−4.2%
Recursion PharmaceuticalsRXRX	Open-market sale10b5-1 plan	04/07	04/08	40,000 sh	$3.10	$124,000	−4.2%
Recursion PharmaceuticalsRXRX	Open-market sale10b5-1 plan	03/23	03/25	40,000 sh	$3.25	$130,000	−4.2%
Recursion PharmaceuticalsRXRX	Open-market sale10b5-1 plan	02/19	02/19	40,000 sh	$3.46	$138,400	−4.2%
Recursion PharmaceuticalsRXRX	Open-market sale10b5-1 plan	02/04	02/06	40,000 sh	$4.12	$164,800	−4.2%
Recursion PharmaceuticalsRXRX	Open-market sale10b5-1 plan	01/20	01/22	40,000 sh	$4.47	$178,800	−4.2%
Recursion PharmaceuticalsRXRX	Open-market sale10b5-1 plan	01/05	01/07	40,000 sh	$4.25	$170,000	−4.1%
Recursion PharmaceuticalsRXRX	Open-market sale10b5-1 plan	25/12/19	25/12/19	40,000 sh	$4.50	$180,000	−4.2%
Recursion PharmaceuticalsRXRX	Open-market sale10b5-1 plan	25/12/04	25/12/05	40,000 sh	$4.63	$185,200	−4.1%
Recursion PharmaceuticalsRXRX	Open-market sale10b5-1 plan	25/11/19	25/11/19	40,000 sh	$4.16	$166,400	−4.2%
Recursion PharmaceuticalsRXRX	Open-market sale10b5-1 plan	25/11/04	25/11/06	40,000 sh	$5.21	$208,400	−3.9%
Recursion PharmaceuticalsRXRX	Open-market sale10b5-1 plan	25/10/23	25/10/24	100,000 sh	$5.70	$570,000	−9.5%
Recursion PharmaceuticalsRXRX	Open-market sale10b5-1 plan	25/10/10	25/10/10	100,000 sh	$6.04	$604,000	−9.3%
Recursion PharmaceuticalsRXRX	Open-market sale10b5-1 plan	25/09/25	25/09/26	100,000 sh	$4.76	$476,000	−9.5%
Recursion PharmaceuticalsRXRX	Open-market sale10b5-1 plan	25/09/10	25/09/12	100,000 sh	$4.71	$471,000	−9.3%
Recursion PharmaceuticalsRXRX	Open-market sale10b5-1 plan	25/08/26	25/08/28	100,000 sh	$4.84	$484,000	−9.5%
Recursion PharmaceuticalsRXRX	Open-market sale10b5-1 plan	25/08/11	25/08/13	618,175 sh3 trades	$5.28avg.	$3,263,964	No record